- JP-listed companies
- BrightPath Biotherapeutics Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.JP:4594
Market cap
¥3.7B
P/E ratio
| Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Net sales | 822 | 823 | 530 | 354 | 156 | 11 | 3 | 15 | 5 | 0 |
| Research and development costs | 764 | 768 | - | - | 67 | 1 | 1 | 0 | 0 | 0 |
| Cost of other sales | - | - | - | - | - | - | - | 3 | 2 | - |
| Cost of sales | 767 | 772 | 525 | 315 | 71 | 4 | 1 | 3 | 2 | 0 |
| Gross profit (loss) | 55 | 51 | 5 | 39 | 85 | 7 | 1 | 12 | 3 | 0 |
| Selling, general and administrative expenses | 547 | 1,040 | 1,118 | 1,601 | 1,751 | 1,834 | 1,734 | 1,488 | 1,470 | 1,155 |
| Operating profit (loss) | -492 | -989 | -1,114 | -1,562 | -1,666 | -1,827 | -1,733 | -1,476 | -1,467 | -1,155 |
| Interest income | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| Other | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
| Non-operating income | 86 | 14 | 13 | 1 | 20 | 3 | 3 | 0 | 1 | 0 |
| Interest expenses on bonds | - | - | - | - | - | - | - | 0 | 0 | - |
| Foreign exchange losses | 1 | - | 2 | - | 4 | - | - | 3 | 5 | 3 |
| Share issuance costs | 5 | 18 | 14 | 12 | - | - | 9 | 2 | 2 | 1 |
| Other | - | - | 1 | 0 | - | - | - | - | 0 | 0 |
| Non-operating expenses | 8 | 18 | 16 | 12 | 33 | 0 | 9 | 6 | 7 | 4 |
| Ordinary profit (loss) | -414 | -993 | -1,117 | -1,573 | -1,678 | -1,824 | -1,739 | -1,482 | -1,474 | -1,159 |
| Impairment losses | - | - | - | - | 195 | 48 | 10 | 6 | 10 | 7 |
| Other | - | - | - | - | 0 | - | - | 0 | - | - |
| Extraordinary losses | 0 | - | 0 | - | 202 | 48 | 10 | 6 | 10 | 7 |
| Profit (loss) before income taxes | -408 | -993 | -1,117 | -1,573 | -1,881 | -1,860 | -1,717 | -1,482 | -1,484 | -1,166 |
| Income taxes - current | 2 | 2 | 3 | 5 | 4 | 3 | 2 | 2 | 2 | 2 |
| Income taxes | 4 | 1 | 5 | 5 | 4 | -2 | 2 | 2 | 2 | 2 |
| Profit (loss) | -412 | -994 | -1,122 | -1,578 | -1,884 | -1,858 | -1,720 | -1,484 | -1,486 | -1,168 |